CTI, or Pfizer’s Centers for Therapeutic Innovation, is a unique program that partners with leading academic medical centers and foundations nationwide in an effort to speed the translation of novel targets to the clinic.Pre-Proposal Deadline: October 16, 2015
Advantages to Collaborating with CTI
A partnership with CTI may include collaborative use of Pfizer’s technologies and compound library, publishing rights, and financial awards in the form of milestone and royalty payments for successful programs, in addition to providing appropriate funds for carrying out the collaborative work.
All researchers and clinicians whose work meets the criteria are invited to apply.
Read criteria here and pre-proposal template is here.
No comments:
Post a Comment